source
- STAT+: Bracing for another Fauci hearingPlus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.
- STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trialsNew GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward long-term growth.